From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 1,285.00
+1.00 (0.08%)
At close: Apr 29, 2026
From Bio Co.,Ltd Revenue
In the year 2025, From Bio Co.,Ltd had annual revenue of 72.16B KRW with 7.41% growth. From Bio Co.,Ltd had revenue of 19.51B in the quarter ending December 31, 2025, with 12.03% growth.
Revenue
72.16B
Revenue Growth
+7.41%
P/S Ratio
0.50
Revenue / Employee
515.44M
Employees
140
Market Cap
35.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.16B | 4.98B | 7.41% |
| Dec 31, 2024 | 67.18B | 457.90M | 0.69% |
| Dec 31, 2023 | 66.72B | -32.61B | -32.83% |
| Dec 31, 2022 | 99.33B | -35.77B | -26.48% |
| Dec 31, 2021 | 135.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moorim SP | 205.67B |
| Zungwon En-Sys | 200.90B |
| System and Application Technologies | 159.73B |
| Dt&C Co., Ltd. | 125.83B |
| WIZ CORP | 112.64B |
| Innodep | 70.74B |
| Fine DNC | 65.79B |
| New Kids On | 49.03B |